File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Sentinel lymph node mapping in endometrial cancer: an updated review

TitleSentinel lymph node mapping in endometrial cancer: an updated review
Authors
Issue Date15-Jul-2022
PublisherHong Kong Academy of Medicine Press
Citation
Hong Kong Journal of Gynaecology, Obstetrics and Midwifery, 2022, v. 22, n. 2 How to Cite?
Abstract

Sentinel lymph node mapping (SLNM) is widely used in staging of both low- and high-risk early-stage endometrial cancer. It has a high detection rate, high sensitivity, high negative predictive value, and low false negative rate in detection of lymph node metastasis. Cervical injection of indocyanine green for SLNM is the preferred method. SLNM reduces the number of lymph node removal and reduces complications from lymphadenectomy without compromising oncological safety. This review discusses the latest evidence of SLNM in endometrial cancer staging in terms of technique, accuracy, limitations, impact on lymphadenectomy complications, and cancer survival.


Persistent Identifierhttp://hdl.handle.net/10722/368228
ISSN

 

DC FieldValueLanguage
dc.contributor.authorLee, Jacqueline HS-
dc.contributor.authorLi, Joshua JX-
dc.date.accessioned2025-12-24T00:36:58Z-
dc.date.available2025-12-24T00:36:58Z-
dc.date.issued2022-07-15-
dc.identifier.citationHong Kong Journal of Gynaecology, Obstetrics and Midwifery, 2022, v. 22, n. 2-
dc.identifier.issn1608-9367-
dc.identifier.urihttp://hdl.handle.net/10722/368228-
dc.description.abstract<p>Sentinel lymph node mapping (SLNM) is widely used in staging of both low- and high-risk early-stage endometrial cancer. It has a high detection rate, high sensitivity, high negative predictive value, and low false negative rate in detection of lymph node metastasis. Cervical injection of indocyanine green for SLNM is the preferred method. SLNM reduces the number of lymph node removal and reduces complications from lymphadenectomy without compromising oncological safety. This review discusses the latest evidence of SLNM in endometrial cancer staging in terms of technique, accuracy, limitations, impact on lymphadenectomy complications, and cancer survival.<br></p>-
dc.languageeng-
dc.publisherHong Kong Academy of Medicine Press-
dc.relation.ispartofHong Kong Journal of Gynaecology, Obstetrics and Midwifery-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleSentinel lymph node mapping in endometrial cancer: an updated review-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.12809/hkjgom.22.2.08-
dc.identifier.volume22-
dc.identifier.issue2-
dc.identifier.eissn2225-904X-
dc.identifier.issnl1608-9367-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats